|
Synonyms: (-)-oxybutynin | (r)-oxybutynin | (R)OXY [3]
Compound class:
Synthetic organic
Comment: Aroxybutynin is the R-enantiomer of racemic oxybutynin. It is reported as the enantiomer that is predominantly responsible for the antimuscarinic effect of oxybutynin [3].
|
|
|||||||||||||||||||||||||||||||||||
| No information available. |
Summary of Clinical Use ![]() |
| Aroxybutynin is being investigated in a fixed-dose combination with atomoxetine (a noradrenaline reuptake inhibitor), as a treatment that is intended to reduce upper airway collapse in patients with obstructive sleep apnoea [1,4,7]. The combination pill is known as AD109 (or Oxnimbi®) [2]. |
| Clinical Trials | |||||
| Clinical Trial ID | Title | Type | Source | Comment | References |
| NCT05811247 | Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo) | Phase 3 Interventional | Apnimed | ||
| NCT05813275 | Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study) | Phase 3 Interventional | Apnimed | 6 | |
| NCT05071612 | Parallel Arm Trial of AD109 and AD504 In Patients With OSA | Phase 2 Interventional | Apnimed | 5 | |